Document is current
Any future updates will be listed below
-
Authors
Zafeiropoulou, Konstantina
Voermans, Bas
Ngo, Huy
Moreno, Javier
Lee, Donghyeok
Derikx, Joep P. M.
Luyer, Misha
Zwinderman, Aeilko H.
Nieuwdorp, Max
de Goffau, Marcus
de Jonge, Wouter J.
Levin, Evgeni
-
Funding
Funding for this research was provided by:
Amsterdam University Medical Centers (09150182010020)
European Research Council (101141346)
- License Information
-
More Information
Article History
Received: 29 July 2024
Accepted: 4 July 2025
First Online: 19 July 2025
Declarations
:
: MN is a member of the Scientific Advisory Board of Caelus Pharmaceuticals and Advanced Microbiome Interventions, the Netherlands (however both of these bear no relations to the content of the current paper). WJ has received speaker’s fees from Alimentiv Bv, and Janssen Pharmaceuticals, over the last 3 years. EL is a board member and employee of HORAIZON BV. HORAIZON BV owns a patent into the technology used under international patent number (WO2023055238A1). The rest of the authors have no conflicts of interest to disclose.
